Spring Bank Pharmaceuticals, Inc. (SBPH): Price and Financial Metrics


Spring Bank Pharmaceuticals, Inc. (SBPH)

Today's Latest Price: $1.28 USD

0.07 (-5.19%)

Updated Sep 25 4:00pm

Add SBPH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SBPH Daily Price Range
SBPH 52-Week Price Range

SBPH Stock Price Chart Technical Analysis Charts


SBPH Price/Volume Stats

Current price $1.28 52-week high $4.80
Prev. close $1.35 52-week low $0.80
Day low $1.27 Volume 60,414
Day high $1.35 Avg. volume 204,954
50-day MA $1.50 Dividend yield N/A
200-day MA $1.53 Market Cap 22.08M

Spring Bank Pharmaceuticals, Inc. (SBPH) Company Bio


Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of a class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. The company was founded in 2002 and is based in Milford, Massachusetts


SBPH Latest News Stream


Event/Time News Detail
Loading, please wait...

SBPH Latest Social Stream


Loading social stream, please wait...

View Full SBPH Social Stream

Latest SBPH News From Around the Web

Below are the latest news stories about Spring Bank Pharmaceuticals Inc that investors may wish to consider to help them evaluate SBPH as an investment opportunity.

IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – SBPH, GLIBA, CBMG, PTI

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Spring Bank Pharmaceuticals, Inc.

Yahoo | September 24, 2020

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of SBPH, NTN, PTI and GLIBA Mergers

WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Spring Bank Pharmaceuticals, Inc. (NASDAQ GS: SBPH) regarding possible breaches of fiduciary duties and other violations of law related to Spring Bank’s agreement to acquire F-star Therapeutics Limited. Under the terms of the agreement, shareholders of Spring Bank will own approximately 38.8% of the combined company and F-star Therapeutics shareholders will own approximately 61.2% of the combined company. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-spring-bank-pharmaceuticals-inc.NTN Buzztime, Inc. (NYSE American: NTN) regarding possible breaches of fiduciary duties and other violations of law related to NTN Buzztime’s agreeme...

Yahoo | September 23, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – DCOM, SBPH, GLIBA, CBMG

NEW YORK, NY / ACCESSWIRE / September 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Dime Community Bancshares, Inc.

Yahoo | September 22, 2020

SHAREHOLDER ALERT: WeissLaw LLP Investigates Spring Bank Pharmaceuticals, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Spring Bank Pharmaceuticals, Inc. ("SBPH" or the "Company") (NASDAQ: SBPH) in connection with SBPH's July 29, 2020 merger and exchange agreement with privately-held biopharmaceutical company, F-star Therapeutics Limited ("F-star"). Under the terms of the proposed transaction, SBPH will acquire the issued capital of F-star and each ordinary share of F-star in exchange for SBPH shares. Following consummation of the proposed transaction, F-star will become a publicly-listed company, with F-star holders owning 61.2% of the combined company and SBPH stockholders owning just 38.8%.

Yahoo | September 22, 2020

Moore Kuehn Encourages RST, AKCA, DCOM, and SBPH Investors to Contact Law Firm

Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies:

Yahoo | September 22, 2020

Read More 'SBPH' Stories Here

SBPH Price Returns

1-mo -2.29%
3-mo -16.88%
6-mo 37.63%
1-year -59.11%
3-year -91.97%
5-year N/A
YTD -18.99%
2019 -84.79%
2018 -22.69%
2017 68.21%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6956 seconds.